(CRH) CRH - Ratings and Ratios
Cement, Aggregates, Readymixed Concrete, Asphalt, Precast Concrete
Description: CRH CRH September 26, 2025
CRH plc, headquartered in Dublin, operates a diversified building-materials business across Ireland, the United States, the United Kingdom, the rest of Europe, and other international markets. The firm is organized into three reporting segments-Americas Materials Solutions, Americas Building Solutions, and International Solutions-each delivering aggregates, cement, ready-mix concrete, mortars, asphalt, and a broad suite of value-added construction products.
The company’s portfolio spans precast and prestressed concrete elements (floor and wall panels, beams, vaults, pipes, and manholes), polymer-based underground vaults and drainage systems, as well as engineered steel and polymer anchoring solutions. Complementary offerings include crushed stone, sand, gravel, hardscape products (pavers, blocks, curbs), fencing, railing systems, composite decking, and packaged concrete mixes for residential, commercial, infrastructure, and outdoor-living projects.
Key recent performance metrics (FY 2023) show revenue of approximately €30.5 billion, an adjusted EBITDA margin of ~12 %, and a net-debt-to-EBITDA ratio of 2.1×. The firm paid a dividend yielding about 4.3 % and returned €1.4 billion to shareholders via buy-backs and payouts, reflecting a capital-allocation policy that prioritizes cash generation.
CRH’s earnings are most sensitive to three macro drivers: (1) U.S. housing-starts and public-infrastructure spending, which together account for roughly 45 % of consolidated revenue; (2) European inflation and energy-price volatility that affect cement and steel input costs; and (3) the sector-wide transition toward low-carbon building materials, where CRH is investing in alternative cements and recycled-aggregate solutions to meet tightening EU emissions standards.
For a deeper, data-driven assessment of CRH’s valuation dynamics and scenario analysis, you may find ValueRay’s analytical tools useful.
CRH Stock Overview
| Market Cap in USD | 78,744m |
| Sub-Industry | Construction Materials |
| IPO / Inception | 1993-02-19 |
CRH Stock Ratings
| Growth Rating | 76.3% |
| Fundamental | 54.2% |
| Dividend Rating | 50.0% |
| Return 12m vs S&P 500 | 12.0% |
| Analyst Rating | 4.43 of 5 |
CRH Dividends
| Dividend Yield 12m | 1.24% |
| Yield on Cost 5y | 4.57% |
| Annual Growth 5y | 10.95% |
| Payout Consistency | 90.0% |
| Payout Ratio | 29.5% |
CRH Growth Ratios
| Growth Correlation 3m | 87.2% |
| Growth Correlation 12m | 37% |
| Growth Correlation 5y | 84.9% |
| CAGR 5y | 53.68% |
| CAGR/Max DD 3y (Calmar Ratio) | 1.99 |
| CAGR/Mean DD 3y (Pain Ratio) | 10.14 |
| Sharpe Ratio 12m | 0.52 |
| Alpha | 10.08 |
| Beta | 1.252 |
| Volatility | 24.42% |
| Current Volume | 2943.7k |
| Average Volume 20d | 3031.2k |
| Stop Loss | 114.3 (-3%) |
| Signal | 1.73 |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (2.91b TTM) > 0 and > 6% of Revenue (6% = 1.98b TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA -1.44pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.64% (prev 14.02%; Δ 5.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 4.53b > Net Income 2.91b (YES >=105%, WARN >=100%) |
| Net Debt (14.28b) to EBITDA (6.45b) ratio: 2.21 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (677.7m) change vs 12m ago -1.61% (target <= -2.0% for YES) |
| Gross Margin 35.89% (prev 34.86%; Δ 1.02pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 64.52% (prev 67.71%; Δ -3.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.28 (EBITDA TTM 6.45b / Interest Expense TTM 639.3m) >= 6 (WARN >= 3) |
Altman Z'' 3.70
| (A) 0.12 = (Total Current Assets 15.15b - Total Current Liabilities 8.68b) / Total Assets 53.98b |
| (B) 0.45 = Retained Earnings (Balance) 24.11b / Total Assets 53.98b |
| (C) 0.09 = EBIT TTM 4.65b / Avg Total Assets 51.04b |
| (D) 0.80 = Book Value of Equity 24.39b / Total Liabilities 30.35b |
| Total Rating: 3.70 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.16
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 2.15% = 1.08 |
| 3. FCF Margin 6.08% = 1.52 |
| 4. Debt/Equity 0.77 = 2.21 |
| 5. Debt/Ebitda 2.21 = -0.41 |
| 6. ROIC - WACC (= 0.78)% = 0.98 |
| 7. RoE 13.41% = 1.12 |
| 8. Rev. Trend -31.09% = -2.33 |
| 9. EPS Trend -29.95% = -1.50 |
What is the price of CRH shares?
Over the past week, the price has changed by +0.80%, over one month by +3.30%, over three months by +22.14% and over the past year by +31.70%.
Is CRH a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CRH is around 147.56 USD . This means that CRH is currently undervalued and has a potential upside of +25.19% (Margin of Safety).
Is CRH a buy, sell or hold?
- Strong Buy: 14
- Buy: 5
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CRH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 133.9 | 13.6% |
| Analysts Target Price | 133.9 | 13.6% |
| ValueRay Target Price | 165.1 | 40% |
CRH Fundamental Data Overview October 20, 2025
P/E Trailing = 24.6247
P/E Forward = 19.305
P/S = 2.1665
P/B = 3.6364
P/EG = 2.5729
Beta = 1.252
Revenue TTM = 32.93b USD
EBIT TTM = 4.65b USD
EBITDA TTM = 6.45b USD
Long Term Debt = 14.64b USD (from longTermDebt, last quarter)
Short Term Debt = 1.42b USD (from shortTermDebt, last quarter)
Debt = 17.16b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 14.28b USD (from netDebt column, last quarter)
Enterprise Value = 93.02b USD (78.74b + Debt 17.16b - CCE 2.88b)
Interest Coverage Ratio = 7.28 (Ebit TTM 4.65b / Interest Expense TTM 639.3m)
FCF Yield = 2.15% (FCF TTM 2.00b / Enterprise Value 93.02b)
FCF Margin = 6.08% (FCF TTM 2.00b / Revenue TTM 32.93b)
Net Margin = 8.85% (Net Income TTM 2.91b / Revenue TTM 32.93b)
Gross Margin = 35.89% ((Revenue TTM 32.93b - Cost of Revenue TTM 21.11b) / Revenue TTM)
Gross Margin QoQ = 39.45% (prev 27.19%)
Tobins Q-Ratio = 1.72 (Enterprise Value 93.02b / Total Assets 53.98b)
Interest Expense / Debt = 1.00% (Interest Expense 170.7m / Debt 17.16b)
Taxrate = 24.19% (362.8m / 1.50b)
NOPAT = 3.53b (EBIT 4.65b * (1 - 24.19%))
Current Ratio = 1.74 (Total Current Assets 15.15b / Total Current Liabilities 8.68b)
Debt / Equity = 0.77 (Debt 17.16b / totalStockholderEquity, last quarter 22.34b)
Debt / EBITDA = 2.21 (Net Debt 14.28b / EBITDA 6.45b)
Debt / FCF = 7.13 (Net Debt 14.28b / FCF TTM 2.00b)
Total Stockholder Equity = 21.74b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.40% (Net Income 2.91b / Total Assets 53.98b)
RoE = 13.41% (Net Income TTM 2.91b / Total Stockholder Equity 21.74b)
RoCE = 12.79% (EBIT 4.65b / Capital Employed (Equity 21.74b + L.T.Debt 14.64b))
RoIC = 9.65% (NOPAT 3.53b / Invested Capital 36.57b)
WACC = 8.86% (E(78.74b)/V(95.90b) * Re(10.63%) + D(17.16b)/V(95.90b) * Rd(1.00%) * (1-Tc(0.24)))
Discount Rate = 10.63% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.98%
[DCF Debug] Terminal Value 65.26% ; FCFE base≈2.19b ; Y1≈1.80b ; Y5≈1.28b
Fair Price DCF = 23.80 (DCF Value 15.95b / Shares Outstanding 670.4m; 5y FCF grow -21.77% → 3.0% )
EPS Correlation: -29.95 | EPS CAGR: -62.18% | SUE: -3.31 | # QB: 0
Revenue Correlation: -31.09 | Revenue CAGR: -1.35% | SUE: -0.34 | # QB: 0
Additional Sources for CRH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle